Showing results (271-280 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapyZhiwei Zhang, Dawei Cui, Hao Wang, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumabI-Wen Chen, Cheng-Wei Lin, Po-Ting Lin, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
IRAK4 Regulates NF-κB signaling to suppress CD8 + T cell activity and promote immune evasion in glioblastoma developmentZhaoliang Xue, Zhengfei Song, Lianjie Mo, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future ChallengesQinghuizi Luo, Wendi Jiang, Yiyang Xie, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapyDiane Evrard, Aurélie Beaufrère, Clément Dumont, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective studyJingyuan Wen, Xinyi Liu, Yuanji Xu, et al.
Cancer Immunology, Immunotherapy : CII|March 25, 2025
Ex vivo-expanded and activated haploidentical natural killer cells infusion before autologous stem cell transplantation in high-risk neuroblastoma: a phase I/II pilot studyTahereh Rostami, Mohammad Ahmadvand, Morteza Azari, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2025
Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational studyJie Gao, Aihua Lan, Xi Yang, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2013
CD40 immunotherapy for pancreatic cancerRobert H Vonderheide, David L Bajor, Rafael Winograd, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2013
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cellsDhifaf Sarhan, Erik Wennerberg, Padraig D'Arcy, et al.
Pageof 650